Detailed price information for Medicus Pharma Ltd (MDCX-Q) from The Globe and Mail including charting and trades.
Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs ...
Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to announce the company has released topline results from its Phase 2 clinical study (SKNJCT-003) evaluating the safety and ...
Detailed price information for Pharmather Hldgs Ltd (PHRRF) from The Globe and Mail including charting and trades.
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty pharmaceutical company focused on unlocking the ...
As shelf-stable microarray patch (MAP) platforms move through development and clinical work, a ‘packaging first’ mentality is needed for industry-wide adoption. Microarray patch (MAP) technology has ...
Abstract: In order to solve the problem that the trajectory tracking control of medical delivery robots is difficult to adapt to the complex and changeable hospital environment, an adaptive ...
Aging means “becoming a target” of the industry, one expert said. After decades of debate, politicians of all stripes are proposing bans. By Paula Span Tamar Abrams had a lousy couple of years in 2022 ...
What do eye doctors have to do with drug addiction? New research from Massachusetts ophthalmologists shows the profession can be an important intervention point for patients experiencing substance use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results